NASDAQ:CRNX

Crinetics Pharmaceuticals Stock Forecast

etoro logo Buy CRNX
*Your capital is at risk
$35.75
+0.750 (+2.14%)
At Close: Jun 17, 2026
AI Analysis AI Analysis of CRNX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CRNX to Watchlist?
Some Reasons Why To Add CRNX:
  • High gross margin of 98.9%
  • Lower volatility than the market (beta 0.24)
  • Low bankruptcy risk (Altman Z-Score: 16.48)
PDF

Stronger technical forecast for Crinetics Pharmaceuticals Inc stock price after Wednesday trading
(Updated on Jun 17, 2026)

Hold candidate since Jun 17, 2026

The Crinetics Pharmaceuticals Inc stock price gained 2.14% on the last trading day (Wednesday, 17th Jun 2026), rising from $35.00 to $35.75. During the last trading day the stock fluctuated 4.63% from a day low at $34.79 to a day high of $36.40. The price has risen in 6 of the last 10 days and is up by 8.04% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 78 thousand more shares were traded than the day before. In total, 721 thousand shares were bought and sold for approximately $25.79 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.06% during the next 3 months and, with a 90% probability hold a price between $30.19 and $39.70 at the end of this 3-month period.

CRNX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 9.63%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Crinetics Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $36.46. On a fall, the stock will find some support from the short-term average at $34.74. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Crinetics Pharmaceuticals Inc stock

Crinetics Pharmaceuticals Inc finds support from accumulated volume at $35.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.61 between high and low, or 4.63%. For the last week, the stock has had daily average volatility of 4.75%.

Our recommended stop-loss: $34.22 (-4.29%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (CRNX) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Crinetics Pharmaceuticals Inc to open at $35.65, and during the day (based on 14 day Average True Range), to move between $34.92 and $36.58, which gives a possible trading interval of +/-$1.66 (+/-4.75%) up or down from last closing price. If Crinetics Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 4.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $35.55 (0.56%) than the resistance at $37.48 (4.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Crinetics Pharmaceuticals Inc stock A Buy?

Crinetics Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.423 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 18, 2026 - $35.65 ( 0.289%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CRNX Performance

Trading levels for CRNX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 37.26 4.21%
R2 36.64 2.49%
R1 36.26 1.43%
Price 35.75
S1 35.03 -2.01%
S2 34.65 -3.07%
S3 34.04 -4.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 43.48 21.61%
R2 38.44 7.52%
R1 37.48 4.84%
Price 35.75
S1 35.55 -0.559%
S2 34.71 -2.91%
S3 33.53 -6.21%

FAQ

What is the symbol for Crinetics Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Crinetics Pharmaceuticals Inc is CRNX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Crinetics Pharmaceuticals Inc Stock.

What's the current price of Crinetics Pharmaceuticals Inc Stock?
As of the end of day on the Jun 17, 2026, the price of an Crinetics Pharmaceuticals Inc (CRNX) share was $35.75.

What is the 52-week high and low for Crinetics Pharmaceuticals Inc Stock?
The 52-week high for Crinetics Pharmaceuticals Inc Stock is $57.99 and the 52-week low is $25.83.

What is the market capitalization of Crinetics Pharmaceuticals Inc Stock?
As of the Jun 17, 2026, the market capitalization of Crinetics Pharmaceuticals Inc is 3.769B.

When is the next earnings date for Crinetics Pharmaceuticals Inc?
The upcoming earnings date for Crinetics Pharmaceuticals Inc is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT CRINETICS PHARMACEUTICALS INC
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE